A new study led by Dr. Mehdi Razavi, Director of Electrophysiology Clinical Research and Innovations at The Texas Heart Institute...
A new medical device initiated at The Texas Heart Institute at Baylor College of Medicine, has received FDA Breakthrough Device...
The Texas Heart Institute at Baylor College of Medicine’s Gene Editing Lab has been awarded a highly competitive NIH R01...
Published in Nature Biomedical Engineering, the breakthrough highlights a novel energy-based technique that could transform the future of arrhythmia care...
International trial shows aficamten outperforms standard beta-blocker therapy in patients with obstructive hypertrophic cardiomyopathy. Ajith Nair, MD, Associate Professor...
Dr. Christie Ballantyne contributes to global study demonstrating the drug’s potential. A newly published international study, “Safety and Efficacy of...
Sadly, every day, lives are lost not because lungs aren’t donated—but because donated lungs don’t arrive in time, or arrive...
Triglycerides are a vital source of energy, but when levels become dangerously high, they can lead to serious health complications,...
A groundbreaking study led by a multi-national team, including key researchers from The Texas Heart Institute (THI), is reshaping our...
Revolutionary BiVACOR heart device moves to phase 2 of FDA trial (click here to watch story) HOUSTON — In a...
Researchers at The Texas Heart Institute (THI)—Camila Hochman-Mendez, Fernanda C. Paccola Mesquita, Ernesto Curty da Costa, Angel Moctezuma-Ramirez, and Abdelmotagaly...
Hydrogel Advance Offers Proof of Concept for New Heart Pacing Technology Innovators at The Texas Heart Institute at Baylor College...
Visit U.S. News & World Report
